Effect of portal venous flow augmentation on liver enhancement with CT

Clicks: 186
ID: 118967
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #67 of 69 articles by views in abdominal imaging

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Background: The purpose of this study was to evaluate the effect of portal flow augmentation on hepatic computed tomographic (CT) enhancement. Methods: Thirteen patients undergoing follow-up CT of the liver within 6 months of initial study ingested 470 mL of Ensure® 30 min before the second examination. Contrast medium injection and scanning parameters were identical for both studies. Results: The time to peak and the maximum and mean liver enhancements were 68 s, 56 HU, and 46 HU, respectively, for the examinations without Ensure® and 68 s, 53 HU, and 44 HU for the examinations with Ensure®. No significant difference was found between the two groups when mean liver enhancement was calculated over 3-s time intervals. Conclusion: Portal venous flow augmentation induced by a meal had no effect on liver enhancement.
Reference Key
garcia2014abdominaleffect Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal abdominal imaging
Year 2014
DOI
doi:10.1007/s002619900189
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.